pharmaceutical companies

Drug Discovery Informatics Market This report presents information related to key drivers, restraints and opportunities, along with a detailed analysis of the drug discovery informatics market share.…

Mines and Steel Development Minister Arc Olamilekan Adegbite said the establishment of the clusters in the six geopolitical zones is part of the federal government's efforts to boost the economy after the adverse effects of the…

TEL AVIV, Israel, February 10, 2022 /PRNewswire/ -- CytoReasona leading developer of computational disease models for effective drug discovery and development, today announced the extension of its collaboration agreement with Pfizer.…

Artificial intelligence and other forms of advanced data analysis are often seen as completely unbiased and unbiased. However, when the people who set up the processes inadvertently introduce bias, the results can be impacted.Rich…

AAmid growing concerns about antibiotic resistance, the US Department of Health and Human Services is set to encourage Congress to create a new incentive program for pharmaceutical companies to develop these life-saving drugs. In a…

The need for animal testing is sad for the drug discovery process, but there is apparently no good alternative to mice, even if they are not particularly accurate human analogues. Quris claims to have the first real option in its…

CytoReason, an Israeli company that uses artificial intelligence (AI) to create disease models for drug discovery and development, announced a partnership with Japanese pharmaceutical services company Summit Pharmaceuticals International.…

Posted on August 30, 2021 | Through Jeff Craven A new drug development model released by the Congressional Budget Office (CBO) estimates that a Medicare drug pricing bill…

With the launch of Protodigm, founder and CEO Mike Rea (also founder and CEO of sister company IDEA Pharma) hopes to "revolutionize" the field of drug development. The company has brought together a diverse group of professionals…

CARY, North Carolina, May 26, 2021 /PRNewswire/ -- CATO SMS, a global provider of regulatory and clinical research services, today announced the acquisition of Nuventra, Inc. to expand its offering in the critical area of ​​clinical…

SAN FRANCISCO, May 25, 2021 /PRNewswire/ -- Curebase announced today $15 million in Series A funding to continue to develop its decentralized clinical trial software platform and virtual research site capabilities, fueling research where…